Stay updated on HER2/EGFR Mutant Tumors Clinical Trial
Sign up to get notified when there's something new on the HER2/EGFR Mutant Tumors Clinical Trial page.

Latest updates to the HER2/EGFR Mutant Tumors Clinical Trial page
- CheckyesterdayChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.0%

- Check8 days agoChange DetectedA banner announces upcoming changes to NIH websites and notes that agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.”SummaryDifference0.3%

- Check15 days agoChange DetectedThe site footer revision advances from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check22 days agoChange DetectedThe site revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check43 days agoChange DetectedThe record history now shows Revision: v3.7.0, replacing the previous Revision: v3.6.6. This indicates a software version update for the history view rather than any changes to study data or text.SummaryDifference0.0%

- Check64 days agoChange DetectedThe revision tag on the page was updated from v3.6.5 to v3.6.6, indicating a newer version of the page. This update affects metadata rather than core content.SummaryDifference0.0%

Stay in the know with updates to HER2/EGFR Mutant Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HER2/EGFR Mutant Tumors Clinical Trial page.